Cynosure, Inc. develops, manufactures, and markets aesthetic treatment systems primarily to the dermatology, plastic surgery, and general medical markets. Its aesthetic treatment systems incorporate a range of laser and other light-based energy sources, including Alexandrite, pulse dye, Nd:Yag, and diode lasers, as well as intense pulsed light. The company’s aesthetic treatment systems comprise Elite product line for hair removal, treatment of facial, and leg veins and pigmentations; Smartlipo product line for LaserBodySculpting for the removal of unwanted fat; Cellulaze product line for the treatment of cellulite; SmoothShapes XV product line for the temporary reduction in the appearance of cellulite; Affirm/SmartSkin product line for anti-aging applications, including treatments for wrinkles, skin texture, skin discoloration, and skin tightening; Cynergy product line for the treatment of vascular lesions; and Accolade, MedLite C6, and RevLite product lines for the removal of benign pigmented lesions, as well as multi-colored tattoos. It also distributes the PinPointe FootLaser, a light-based device for the treatment of onychomycosis. The company sells its products through a direct sales force in North America, France, Spain, the United Kingdom, Germany, Korea, China, Japan, and Mexico, as well as through independent distributors in approximately 100 countries. Cynosure, Inc. was founded in 1991 and is headquartered in Westford, Massachusetts.

Key Statistics